Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Pacific Biosciences of California Inc
NASDAQ:PACB

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
NASDAQ:PACB
Watchlist
Price: 1.845 USD 0.27%
Market Cap: $557m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

PACB Price Targets Summary
Pacific Biosciences of California Inc

Wall Street analysts forecast PACB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PACB is 2.259 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.

PACB Lowest Forecast
Wall Street Target
1.01 USD
-45% Downside
PACB Average Forecast
Wall Street Target
2.259 USD
22% Upside
PACB Highest Forecast
Wall Street Target
3.15 USD
71% Upside
Lowest
Price Target
1.01 USD
45% Downside
Average
Price Target
2.259 USD
22% Upside
Highest
Price Target
3.15 USD
71% Upside
Pacific Biosciences of California Inc Competitors:
Price Targets
SGA
Saga Communications Inc
62% Upside
SAMG
Silvercrest Asset Management Group Inc
45% Upside
WEED
Canopy Growth Corp
143% Upside
BWXT
BWX Technologies Inc
15% Upside
SGA
Saga Communications Inc
62% Upside
SAMG
Silvercrest Asset Management Group Inc
45% Upside
WEED
Canopy Growth Corp
143% Upside
BWXT
BWX Technologies Inc
15% Upside

Revenue
Forecast

12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 13 years the compound annual growth rate for Pacific Biosciences of California Inc's revenue is 12%. The projected CAGR for the next 4 years is 11%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss

What are analyst estimates?

See Also

Summary
PACB intrinsic value, competitors valuation, and company profile.
DCF Valuation
PACB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PACB stock valuation using valuation multiples.
Wall Street Estimates
PACB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PACB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PACB's stock price target?
Price Target
2.259 USD

According to Wall Street analysts, the average 1-year price target for PACB is 2.259 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.

What is Pacific Biosciences of California Inc's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Pacific Biosciences of California Inc's revenue is 12%. The projected CAGR for the next 4 years is 11%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.